NCT06992193

Brief Summary

This multicenter randomized controlled clinical trial was conducted to evaluate the effectiveness of digital anesthesia using a computer-controlled intraosseous system (SleeperOne 5®) compared to traditional local anesthesia techniques (infiltration and mandibular block) in paediatric dental patients. A total of 79 children aged 6-12 years were randomly assigned to one of three groups. Pain perception, anxiety levels, and behavioral responses were assessed using validated tools including the Wong-Baker FACES Pain Scale, the Modified Child Dental Anxiety Scale (MCDAS), and the FLACC behavioral scale. The study aimed to determine whether digital anesthesia could provide a less painful and less anxiety-inducing experience for children during dental treatment. Findings may support broader clinical adoption of computer-assisted anesthetic delivery in paediatric dentistry.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 8, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 9, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 28, 2025

Completed
Last Updated

May 28, 2025

Status Verified

May 1, 2025

Enrollment Period

3 months

First QC Date

May 9, 2025

Last Update Submit

May 24, 2025

Conditions

Keywords

Dental AnxietyPain ManagementIntraosseous anesthesiaLocal Anesthesia

Outcome Measures

Primary Outcomes (1)

  • Wong-Baker FACES pain scores at three time points

    Pain was assessed using the Wong-Baker FACES Pain Rating Scale at three stages: (1) needle insertion, (2) anesthetic delivery, and (3) during dental treatment. Scores range from 0 (no hurt) to 10 (hurts worst).

    Time Frame: Immediately before needle insertion, during anesthetic delivery at the time of the procedure, and during dental procedure (Day 1)

Secondary Outcomes (2)

  • Change in MCDAS anxiety scores before and after treatment

    Day 1 - immediately before and after dental procedure

  • FLACC behavioral pain scores during anesthesia

    Periprocedural (Day 1) - during anesthetic injection phase

Study Arms (3)

Digital Anesthesia

EXPERIMENTAL

Children receiving intraosseous local anesthesia via a computer-controlled delivery system (SleeperOne 5®) using 4% articaine with 1:200,000 epinephrine.

Device: Digital Anesthesia

Infiltration Anesthesia

ACTIVE COMPARATOR

Children receiving traditional infiltration anesthesia using 2% lidocaine with 1:100,000 epinephrine via standard dental syringe.

Drug: Infiltration Anesthesia

Mandibular Block Anesthesia

ACTIVE COMPARATOR

Children receiving conventional inferior alveolar nerve block with 2% lidocaine and 1:100,000 epinephrine using a long dental needle.

Drug: Mandibular Block

Interventions

Computer-controlled intraosseous anesthesia system (Dental Hi Tec, France) used to deliver 1.3 mL of 4% articaine with 1:200,000 epinephrine in two stages: gingival and intraosseous injection. The system provides consistent flow and reduced pain perception in children.

Also known as: SleeperOne 5
Digital Anesthesia

1 mL of 2% lidocaine with epinephrine was delivered via buccal infiltration using a conventional aspirating syringe and 27-gauge short needle. Topical benzocaine gel was applied for 30 seconds prior to injection.

Also known as: Lidocaine hydrochloride 2% with epinephrine 1:100,000
Infiltration Anesthesia

1 mL of lidocaine was administered using the inferior alveolar nerve block technique via a conventional dental syringe and 27-gauge long needle. Negative aspiration was confirmed prior to slow deposition.

Also known as: IANB
Mandibular Block Anesthesia

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 6 to 12 years
  • ASA I or II health status
  • Cooperative behavior (Frankl score 3-4 or Venham score 0-2)
  • Indicated for restorative, endodontic, or extraction treatment on primary teeth
  • No prior local anesthesia experience during the previous 6 months

You may not qualify if:

  • Presence of systemic or neurological diseases
  • Use of analgesics within 48 hours before the procedure
  • Uncooperative behavior (Frankl score 1-2 or Venham score \>2)
  • Incomplete cooperation during the procedure
  • Allergy to articaine, lidocaine, or epinephrine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

İstanbul Beykent University Faculty of Dentistry Department of Pediatric Dentistry

Istanbul, 34500, Turkey (Türkiye)

Location

Ege University Faculty of Dentistry Department of Pediatric Dentistry

Izmir, 35100, Turkey (Türkiye)

Location

Related Publications (1)

  • Atesci AA, Korkut Isik B, Yilmaz DO, Gergit B, Kilic MC, Oncag RO. Is Digital Anesthesia a Viable Alternative for Pain and Anxiety Control in Pediatric Dentistry? Int J Paediatr Dent. 2025 Oct 25. doi: 10.1111/ipd.70048. Online ahead of print.

MeSH Terms

Conditions

Agnosia

Interventions

Anesthesia, LocalLidocaineEpinephrine

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and AnalgesiaAcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesEthanolaminesAmino AlcoholsAlcoholsBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DDS, PhD

Study Record Dates

First Submitted

May 9, 2025

First Posted

May 28, 2025

Study Start

January 8, 2025

Primary Completion

April 1, 2025

Study Completion

April 1, 2025

Last Updated

May 28, 2025

Record last verified: 2025-05

Locations